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Background: Limited studies are available on prevalence and severity of vitamin D deficiency in a critically ill
population. To the best of our knowledge, this the first study of its kind in an Indian intensive care set-up.
Methods: One hundred fifty-eight critically ill patients were prospectively enrolled for over 2 years. Demographic
profile and clinical characteristics were noted. Blood sample for serum 25 (OH) D was collected on admission (4 ml).
Serum 25 (OH) D was measured using radioimmunoassay kit. Vitamin D deficiency was labelled as insufficient
(31–60 nmol/l), deficient (15–30 nmol/l) and undetectable (<15 nmol/l). Statistical tests used were t test, chi-square
test and binary logistic regression.
Results: Vitamin D deficiency (<60 nmol/l) was present in 127 patients (80.4%). Twenty-six patients had (20.47%)
undetectable vitamin D levels. The mean vitamin D level was higher amongst survivors (43.17 + 39.22) than in
non-survivors (39.72 + 29.31). Vitamin D was not significantly associated with mortality in univariate analysis. Multiple
logistic regression showed admission APACHE II (p = 0.008), lactate (p = 0.013) and pre-ICU hospital stay (p = 0.041)
as independent predictors of mortality in critically ill patients (p < 0.05).
Conclusions: Vitamin D deficiency is highly prevalent in critically ill patients. A causal association between vitamin
D deficiency and mortality was not found in our study. Larger studies are needed to understand the relationship
between vitamin D deficiency and ICU outcome.
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The pandemic of vitamin D deficiency even in effluent
societies has pointed out the growing distance of human
race from nature. Recent research has generated interest
in pleiotropic actions of vitamin D all over the world.
Vitamin D receptors are found in nearly all types of
immune cells [1]. Its action on innate immunity is
stimulatory, while its action on adaptive immunity is
mainly considered to be modulatory [2]. Various clinical
studies and trials have shown correlation between* Correspondence: drarminahmed@gmail.com
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stated.vitamin D and systemic infections. Its deficiency has
been associated with acute respiratory tract infections
[3,4], cardiovascular diseases and other chronic illnesses
[5]. Scientists are now exploring its possible association
with acute life-threatening illnesses. A large US-based
study reviewing national database of hospital discharge
from 1979 to 2003 showed seasonal variation in inci-
dence of sepsis and severe sepsis paralleling the seasonal
fluctuation in 25(OH) D levels [6,7]. A recently pub-
lished study showed that vitamin D deficiency prior to
hospital admission predisposes for acute kidney injury in
critically ill patients [8]. We conducted this study to ana-
lyse the prevalence and severity of vitamin D deficiencyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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Table 1 Patients demography (n = 158)
Variable Mean (±SD)















Other ICUs/HDUs (including post-operative ICU) 95
Admission SOFA score 9.56 ± 4.32
Admission APACHE II score 15.35 ± 6.14
Vitamin D levels (nmol/l) 41.53 ± 34.29
Length of ICU stay (days) 16.84 ± 18.44
Days of mechanical ventilation 13.35 ± 17.01
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Indian literature.
Methods
It is a prospective single-centre study conducted in the
department of critical care medicine of a tertiary care
public referral hospital. The intensive care unit (ICU)
admits both medical and surgical cases. Ethical clea-
rance was obtained from the ethical committee of Sanjay
Gandhi Postgraduate Institute of Medical Sciences be-
fore conducting the study. Informed consent was taken
from next of kin of all enrolled patients. This study was
conducted between May 2010 and May 2012.
All consecutive critically ill patients requiring ICU ad-
mission were screened for enrolment for the study. Exclu-
sion criteria included age less than 18 years, pregnancy,
patients on corticosteroid therapy, patients with history of
malabsorption syndrome, patients with chronic kidney
disease (CKD), patients on drugs interfering with vitamin
D metabolism and patients already on vitamin D supple-
mentation. A total of 158 patients (out of 480 admissions)
met the inclusion criteria, and data was analysed for them.
Blood samples for laboratory measurements of serum
25 (OH) D were collected on patients' admission (4 ml),
which were then immediately transferred to the endo-
crinology laboratory. Serum 25 (OH) D was measured
using a radioimmunoassay kit technique using the 12
well gamma Counter machine (STRATEC, Birkenfeld,
Germany). Till the samples were not processed, they
were stored at −20°C temperature after separating the
serum. Vitamin D deficiency was defined as values less
than 60 nmol/l. Severity of vitamin D deficiency was
labelled as insufficient if the level was between 31 and
60 nmol/l, deficient if the level was between 15 and
30 nmol/l and undetectable if the level was less than
15 nmol/l. The demographic profile (age/sex, co-mor-
bidities), admission diagnosis, clinical characteristics and
biochemical parameters of each patient were noted at
the time of enrolment in the study. Severity of critical
illness was assessed by admission acute physiological
and chronic health evaluation (APACHE II) score and
sequential organ failure assessment (SOFA) score. Levels
and severity of vitamin D deficiency were compared
between survivors and non-survivors and correlated with
the outcome. Vitamin D was also compared to other
predictors of outcome like APACHE II, SOFA and total
days of mechanical ventilation. Laboratory and clinical
management was done as per the treating team.
Statistical analysis
Data was analysed using SPSS 16.0, and results were
expressed as mean ± standard deviation or median
(interquartile range) as appropriate. Sample size was de-
cided based on significance level (alpha) = 0.05. Student'st test was used between survivors and non-survivors.
Non-parametric test like chi-square test was used for
comparison between two groups for ranked observation.
Actual p values were reported, and a p value <0.05 was
taken as significant. Multivariate analysis by binary logis-
tic regression was used. All the study variables were con-
sidered, and the best model with five variables which
gave 90.5% overall correct classification was used.
Results and discussion
Results
Of the 158 patients enrolled in the study, there were 97
male patients (61.39%) and 61 female patients (38.60%).
Their mean age, SOFA score, APACHE II score, Vitamin
D levels, average length of stay and average days of
mechanical ventilation are mentioned in Table 1.
Survivors and non-survivors were compared for demo-
graphic characteristics like age, severity of illness (SOFA
and APACHE II) and admission laboratory parameters
which included procalcitonin (PCT), serum albumin,
arterial lactate, serum creatinine and levels of vitamin D
(Table 2). Admission SOFA, APACHE II score, lactates,
days of mechanical ventilation and days of pre-ICU stay
were significantly higher in non-survivors on univariate
analysis. There was no statistically significant difference
in vitamin D levels amongst the two groups (p = 0.53).
Table 2 Patient characteristics: survivors vs non-survivors
Variable Survivors Non-
survivors
t value p value
(n = 75) (n = 83)
(Mean ± SD) (Mean ± SD)
Age (years) 47.01 ± 15.78 50.08 ± 17.05 1.17 0.25
SOFA score 7.96 ± 4.21 11.00 ± 3.94 4.66 0.001
APACHE II score 12.89 ± 5.39 17.50 ± 5.94 5.06 0.001
Procalcitonin
(ng/ml)
14.14 ± 41.29 21.01 ± 60.35 0.82 0.41
Albumin (mg%) 2.74 ± 0.59 2.61 ± 0.59 1.41 0.16
Creatinine (mg%) 2.17 ± 2.20 2.78 ± 1.97 1.83 0.07
Lactate (mg/dl) 16.66 ± 9.72 24.31 ± 18.41 2.82 0.001
Vitamin D (nmol/l) 43.17 ± 39.22 39.72 ± 29.31 0.63 0.53
Pre-ICU hospital stay
(days)
6.0 ± 6.02 10.67 ± 14.54 2.59 0.01
ICU length of stay 19.03 ± 20.98 14.90 ± 15.75 1.40 0.16
Days of MV 10.05 ± 19.55 15.99 ± 13.49 2.23 0.03
MV mechanical ventilation.
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patients (80.4%). Fifty-three patients (41.73%) were in
the insufficient group, 48 patients (37.79%) were in the
deficient group and 26(20.47%) patients had undetec-
table vitamin D levels.
Factors found to be significantly associated with morta-
lity in univariate analysis (SOFA score, APACHE II score,
lactate, pre-ICU stay and days of mechanical ventilation)
were subjected to binary logistic regression. APACHE II
score, lactate and pre-ICU stay were found to be inde-
pendently associated with mortality (Table 3).
Discussion
Vitamin D deficiency is highly prevalent in the gen-
eral population all over the world. Prevalence of
levels <50 nmol/l is reported between 36% and 57% in the
USA and even higher (between 28% and 100%) in
European studies depending upon the group of population






APACHE II −0.106 0.040
Pre-ICU stay −0.061 0.030
Lactate −0.053 0.022
Days of mechanical analysis −0.022 0.012
Constant 4.078 .757
MV mechanical ventilation, OR odds ratio. Degree of freedom = 1.Indian literature suggests vitamin D deficiency between
50% and 90% in the general population [10,11].
Cut-off value of normal range of vitamin D remains a
debatable topic, and whether levels considered normal for
general population can be applied to critically ill patients
remains unclear [12,13]. In our study, we have used
60 nmol/l as the cut-off value based on the study pub-
lished by Lee et al. in 2009 [14]. However, in a recent
meta-analysis of prospective cohort studies, Zitterman
and colleagues reported 75–87.5 nmol/l as the optimal
concentration in the general population and even showed
a non-linear decrease in mortality as circulating 25 (OH)
D level increases [15].
Vitamin D deficiency and its relation with increased
mortality in the general population are well established.
Almost all chronic illnesses associated with ageing are
adversely affected by vitamin D deficiency [16,17]. A
meta-analysis published in 2007 showed that ordinary
dose vitamin D supplementation is associated with re-
duction in total mortality in the general population [18].
Melamed and colleagues reported that vitamin D <17.5 ng/l
is independently associated with mortality in the general
population [19]. Review of literature and clinical studies
on end-stage renal disease patients have shown that
vitamin D supplementation is associated with decreased
mortality [20]. A recently published meta-analysis of 10
studies with a cohort of 6,853 patients concluded that
higher vitamin D levels correlates with improved survival
in CKD patients [21].
Vitamin D deficiency in critical illnesses can be multi-
factorial and can influence the sepsis cascade through
several mechanisms. These mechanisms may include im-
mune modulation, suppression of exaggerated inflam-
matory response, enhanced phagocytosis, chemotaxis,
increased production of antimicrobial peptide cathelici-
din, and calcium and glucose homeostasis [22,23].
Deficiency of vitamin D in a critically ill population has
also been studied, though to a lesser extent. Its association
with mortality in this population subgroup remains un-
clear. Studies have shown a vitamin D deficiency of more
than 90% in a critically ill population [24,25]. Lee et al.or of
ient (beta)
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ted to the ICU [14]. Data regarding vitamin D deficiency
in the critically ill population in the Indian scenario is
lacking. In our study, we found that 80.4% of patients
were deficient (level <60 nmol/l) in vitamin D levels on
admission to the intensive care unit, with 20.48% having
undetectable levels (level <15 nmol/l). However, we
could not find a causal relationship between vitamin D
deficiency and mortality.
Cecchi et al. conducted a single-centre study on 170
patients, out of which 92 were severe sepsis/septic shock
patients and 72 were trauma patients [26]. Vitamin D
levels were significantly lower in the septic group but did
not prove to be a mortality predictor on multivariate ana-
lysis. In contrast, a few studies have shown a significant
association between vitamin D levels and mortality in
critically ill patients [27,28]. Mathews et al. studied the
effect of vitamin D deficiency in 258 surgical ICU patients
and reported an inverse relation between vitamin D defi-
ciency and length of ICU stay, cost of therapy and morta-
lity [29]. Braun et al. studied pre-admission 25(OH) D
levels drawn 7 to 365 days prior to ICU admission in a
large cohort of 2,399 patients [30]. They reported vitamin
D as a strong predictor of ICU mortality. It is postulated
that acute fluid shifts seen in severe sepsis and septic
shock can influence the assessment of correct vitamin D
levels [31]. Venkatesh et al. pointed out the wide fluc-
tuation in vitamin D level occurring in critically ill patients
for hours [32]. This could be one of the causes of different
findings in various studies.
Larger studies are needed to understand the role of
vitamin D level in critical illness, to define supplementa-
tion strategy, in monitoring frequency and in effect of
replacement on outcome. Moreover, redesigning of ICU
set-ups in such a way that all patients get adequate sun-
light might be a topic of debate in modern medicine.
Conclusions
The authors conclude that this study shows high prevalence
of vitamin D deficiency in critical care settings even in tro-
pical countries like India. We also found that APACHE II,
lactate and pre-ICU hospital stay are independent predic-
tors of mortality in critically ill patients. We could not find
a causal association between vitamin D deficiency and
mortality.
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